Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Richman

Showing results (321-330 of 792) with videos related to

Pageof 80
Sort By:
The Journal of Infectious Diseases|October 24, 2013
The global transmission network of HIV-1Joel O Wertheim, Andrew J Leigh Brown, N Lance Hepler, et al.
Journal of Investigational Allergology & Clinical Immunology|January 15, 2020
Clinical Features and Disease Management in Adult Patients With Atopic Dermatitis Receiving Care at Reference Hospitals in Brazil: the ADAPT StudyL K Arruda, A C Yang, V Aoki, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1997
Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151M A Fischl, D D Richman, C Flexner, et al.
HIV Medicine|January 15, 2014
Community HIV-1 drug resistance is associated with transmitted drug resistanceM W Tilghman, J Pérez-Santiago, G Osorio, et al.
Gastroenterology|February 5, 2008
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approachJean-Michel Pawlotsky, Geoffrey Dusheiko, Angelos Hatzakis, et al.
Virology|December 3, 2014
HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencingChristoph C Carter, Gabriel A Wagner, George K Hightower, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|November 24, 2005
Update of the drug resistance mutations in HIV-1: Fall 2005Victoria A Johnson, Francoise Brun-Vezinet, Bonaventura Clotet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trialSusan D Richman, Matthew T Seymour, Philip Chambers, et al.
Journal of Clinical Microbiology|September 24, 2020
Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral TherapySonia Bakkour, Xutao Deng, Peter Bacchetti, et al.
European Journal of Immunology|August 15, 2000
Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunityH Tighe, K Takabayashi, D Schwartz, et al.
Pageof 80

Showing results (321-330 of 792) with videos related to

Sort By:
Pageof 80
The Journal of Infectious Diseases|October 24, 2013
The global transmission network of HIV-1Joel O Wertheim, Andrew J Leigh Brown, N Lance Hepler, et al.
Journal of Investigational Allergology & Clinical Immunology|January 15, 2020
Clinical Features and Disease Management in Adult Patients With Atopic Dermatitis Receiving Care at Reference Hospitals in Brazil: the ADAPT StudyL K Arruda, A C Yang, V Aoki, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1997
Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151M A Fischl, D D Richman, C Flexner, et al.
HIV Medicine|January 15, 2014
Community HIV-1 drug resistance is associated with transmitted drug resistanceM W Tilghman, J Pérez-Santiago, G Osorio, et al.
Gastroenterology|February 5, 2008
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approachJean-Michel Pawlotsky, Geoffrey Dusheiko, Angelos Hatzakis, et al.
Virology|December 3, 2014
HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencingChristoph C Carter, Gabriel A Wagner, George K Hightower, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|November 24, 2005
Update of the drug resistance mutations in HIV-1: Fall 2005Victoria A Johnson, Francoise Brun-Vezinet, Bonaventura Clotet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trialSusan D Richman, Matthew T Seymour, Philip Chambers, et al.
Journal of Clinical Microbiology|September 24, 2020
Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral TherapySonia Bakkour, Xutao Deng, Peter Bacchetti, et al.
European Journal of Immunology|August 15, 2000
Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunityH Tighe, K Takabayashi, D Schwartz, et al.
Pageof 80